These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Topical pimecrolimus in the treatment of human allergic contact dermatitis. Amrol D; Keitel D; Hagaman D; Murray J Ann Allergy Asthma Immunol; 2003 Dec; 91(6):563-6. PubMed ID: 14700441 [TBL] [Abstract][Full Text] [Related]
24. The ubiquitous urushiols Contact dermatitis from mango, poison ivy, and other "poison" plants. 1968. Goldstein N Hawaii Med J; 2004 Aug; 63(8):231-5. PubMed ID: 15485071 [No Abstract] [Full Text] [Related]
34. A murine model system for contact sensitization to poison oak or ivy urushiol components. Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516 [No Abstract] [Full Text] [Related]
35. Dermoscopy of black-spot poison ivy. Rader RK; Mu R; Shi H; Stoecker WV; Hinton KA Dermatol Online J; 2012 Oct; 18(10):8. PubMed ID: 23122015 [TBL] [Abstract][Full Text] [Related]
36. COMPARISON OF THE POTENCY OF POISON IVY EXTRACTS WITH SYNTHETIC PENTADECYLCATECHOL IN SENSITIVE HUMANS. AUERBACH R; BAER H J Allergy; 1964; 35():201-5. PubMed ID: 14160428 [No Abstract] [Full Text] [Related]
37. The saga of poison ivy. Parish LC; Haviland TN Trans Stud Coll Physicians Phila; 1974 Jul; 42(1):88-93. PubMed ID: 4283359 [No Abstract] [Full Text] [Related]
39. A striking therapeutic result. A case report of poison ivy. Bacon M J Maine Med Assoc; 1972 Apr; 63(4):75. PubMed ID: 4336203 [No Abstract] [Full Text] [Related]
40. Poison ivy/oak/sumac. Part II: Specific features. Fisher AA Cutis; 1996 Jul; 58(1):22-4. PubMed ID: 8823544 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]